In this Tech blast episode, we talk CAR-T cell development for cancer immunotherapies with Ritwika Biswas, Product Scientist for Sino Biological. We cover some of the latest developments in the field, the advantages of CAR-T over other immunotherapies and selecting the perfect CAR-T antigen, amongst a whole host of different aspects in the field.

Contents

Introduction: 00:00-00:30

Core principles of cancer immunotherapy: 00:30-02:00

Explaining cancer immunity: 02:00-03:20

Distinguishing CAR-T from native T cells: 03:20-04:40

CAR-T antigen targets: 04:40-06:00

Techniques for engineering CAR-T cells: 06:00-08:00

Introducing off the shelf CAR-T cells: 08:00-09:45

Addressing challenges in off the shelf CAR-T: 09:45-11:30

Current status of CAR-T therapies: 11:30-12:55

Advantages of CAR-T cell therapy over other immunotherapies: 12:55-15:25

The future of CAR-T: 15:10-18:10